Trial Profile
A Randomized, Double-blind, Placebo-controlled, Phase II Study of Silodosin in Patients With Urinary Calculi
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Ureteral calculi
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 09 May 2014 New trial record
- 29 Oct 2013